FR3734M - New piperazine which can be used in therapy, in particular as a hypotensive agent. - Google Patents

New piperazine which can be used in therapy, in particular as a hypotensive agent.

Info

Publication number
FR3734M
FR3734M FR969932A FR969932A FR3734M FR 3734 M FR3734 M FR 3734M FR 969932 A FR969932 A FR 969932A FR 969932 A FR969932 A FR 969932A FR 3734 M FR3734 M FR 3734M
Authority
FR
France
Prior art keywords
therapy
hypotensive agent
new piperazine
piperazine
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR969932A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3734M publication Critical patent/FR3734M/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR969932A 1963-01-14 1964-04-07 New piperazine which can be used in therapy, in particular as a hypotensive agent. Active FR3734M (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25104763A 1963-01-14 1963-01-14
US25778363A 1963-02-11 1963-02-11
US25778463A 1963-02-11 1963-02-11
US27189063A 1963-04-10 1963-04-10
US32134263A 1963-11-04 1963-11-04
US32133463A 1963-11-04 1963-11-04

Publications (1)

Publication Number Publication Date
FR3734M true FR3734M (en) 1965-12-06

Family

ID=27559375

Family Applications (1)

Application Number Title Priority Date Filing Date
FR969932A Active FR3734M (en) 1963-01-14 1964-04-07 New piperazine which can be used in therapy, in particular as a hypotensive agent.

Country Status (5)

Country Link
BE (3) BE642428A (en)
CH (5) CH449634A (en)
DE (1) DE1232587B (en)
FR (1) FR3734M (en)
GB (2) GB1061571A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721715A (en) * 1984-08-07 1988-01-26 Societe Cortial, S.A. Derivatives of 4-(arylpiperazinyl-ethylaminoethoxy) phenol useful for effecting hypolipidemic therapy or cardiovascular therapy

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5513209A (en) * 1978-07-11 1980-01-30 Synthelabo Antidepressive made of piperazine derivative
JPS56115769A (en) * 1980-02-18 1981-09-11 Tanabe Seiyaku Co Ltd Piperazine derivative and its preparation
DE3715763A1 (en) * 1987-05-12 1988-11-24 Hoechst Ag DIARYLALKYL-SUBSTITUTED ALKYLAMINE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND MEDICINAL PRODUCTS CONTAINING THE SAME
JP2002509918A (en) * 1998-03-31 2002-04-02 アケイディア ファーマスーティカルズ インコーポレイテッド Compounds with activity on muscarinic receptors
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721715A (en) * 1984-08-07 1988-01-26 Societe Cortial, S.A. Derivatives of 4-(arylpiperazinyl-ethylaminoethoxy) phenol useful for effecting hypolipidemic therapy or cardiovascular therapy

Also Published As

Publication number Publication date
GB1053301A (en)
BE642427A (en) 1964-07-13
CH449636A (en) 1968-01-15
CH449633A (en) 1968-01-15
BE642429A (en) 1964-07-13
CH449030A (en) 1967-12-31
CH449634A (en) 1968-01-15
BE642428A (en) 1964-07-13
DE1232587B (en) 1967-01-19
GB1061571A (en) 1967-03-15
CH449635A (en) 1968-01-15

Similar Documents

Publication Publication Date Title
AT251427B (en) Capsule work, in particular curve capsule work
FR3290M (en) New amines which can be used in therapy, in particular as inhibitors of mono-aminoxidase.
FR3071M (en) New pancreatic proteases, usable in particular in gastroenterology.
FR3846M (en) New 4-amino-piperidines.
FR3734M (en) New piperazine which can be used in therapy, in particular as a hypotensive agent.
FR3439M (en) New quinazoline which can be used in therapy, in particular as an analgesic.
NL150287B (en) SYNCHRONOUS DEMODULATOR.
FR3539M (en) Compositions comprising 4- (2-amino-4-pyrimidylamino) -benzenesulfamide, useful as hypotensive drugs.
FR3770M (en) New lactones useful as hypocholesteremic agents.
BE647221A (en) 3,5-dialkyl-4-hydroxy-plenylacetic acid derivatives.
FR3309M (en) New piperazine which can be used in therapy, in particular as an antiphlogistic.
FR3817M (en) New anthelmintic.
FR3782M (en) New isoquinoline usable in therapy, in particular as a beaker.
FR3259M (en) New hypoglycemic compositions.
FR3864M (en) New piperazines which can be used in therapy, in particular as hypotensive agents.
FR3504M (en) New phthalazinium compound that can be used in therapy, in particular as a vermicide.
FR2691M (en) New a-nor-b-homo-steroids which can be used in therapy, in particular as gestagenes.
FR3750M (en) New psychotherapeutic agent for use as a drug.
FR3805M (en) New & delta <4> -7α-methyl-17β-hydroxy-19-nor-androstene-3-one usable in therapy.
FR2999M (en) New guanidine which can be used in therapy, in particular as a hypoglycemic agent.
OA00988A (en) Scaffolding.
FR2714M (en) New sulfonamide which can be used in therapy, in particular as a chemotherapeutic agent.
FR3248M (en) New sulfonamide which can be used in therapy, in particular as a chemotherapeutic agent.
FR2745M (en) New sulfonamide which can be used in therapy, in particular as a chemotherapeutic agent.
FR3325M (en) New 2-alkyl-4-pyridine-aldehyde-thiosemicarbazones.